University of Minnesota. Driven to Discover.
A 16-study meta-analysis finds about a 50% higher risk tied to anti-reflux drugs.
Two studies suggest DSM265 is a medium-potency, slowly eliminated, well-tolerated antimalarial.
Last year saw a surge of 136 AFM cases in 37 states.
Four southeastern states have now been hit with low-path H7, with Tennessee also noting high-path H7N9.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2017 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.